ロード中...
Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature
Abstract Background Nivolumab is an immune checkpoint inhibitor targeting programmed death-1 protein and has been approved for the treatment of multiple advanced malignancies. Adverse effects of immune checkpoint inhibitors are distinct from conventional cytotoxic chemotherapy and can be life-threat...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2018-05-01
|
| シリーズ: | Experimental Hematology & Oncology |
| 主題: | |
| オンライン･アクセス: | http://link.springer.com/article/10.1186/s40164-018-0104-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|